Skip to main content
Fig. 4 | Arthritis Research & Therapy

Fig. 4

From: Efficacy of plasma exchange for antineutrophil cytoplasmic antibody-associated systemic vasculitis: a systematic review and meta-analysis

Fig. 4

Forrest plots of primary outcomes between the PE and pulse steroid treatment groups. Regarding the timing of outcome measurement in this figure, mortality and adverse events are for the overall observational period, and clinical remission (BVAS) is at 1 year after the allocation. See Additional file 5 for other data. In this figure, as adverse events, data of only severe or life-threatening cases are displayed. Abbreviations: PE, plasma exchange; BVAS, Birmingham Vasculitis Activity Score

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us